| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 35, 374-379, Copyright © 1989 by American Association for Clinical Chemistry
CB Whitley, MD Ridnour, KA Draper, CM Dutton and JP Neglia
Department of Pediatrics, University of Minnesota Medical School, Minneapolis 55455.
This direct method for quantifying excessive urinary glycosaminoglycan excretion exploits the specific binding of 1,9-dimethylmethylene blue (DMB). The procedure obviates cumbersome and labor-intensive procedures for separating glycosaminoglycans from other constituents of urine. Pediatric pharmaceutical formulations (except heparin), in concentrations expected in urine, do not interfere with spectrophotometry, nor does protein. Results can be expressed in terms of urinary creatinine; thus the test is applicable to very small urine specimens (0.1 mL), such as those obtainable from neonates. In a pilot study, results of the direct DMB test for 48 urine specimens agreed with the clinical diagnosis, and quantitative measurements correlated moderately (r = 0.76) with results of a commonly used procedure (carbazole-borate reactivity after precipitation with cetylpyridinium chloride). The present method was also used to assess metabolic correction in a patient with Hurler's syndrome after treatment by bone- marrow transplantation. This quantitative method surmounts the major technical problems of developing mass screening programs for infants, thus offering the potential for earlier diagnosis and treatment of mucopolysaccharidosis diseases.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  P. Harmatz, D. Ketteridge, R. Giugliani, N. Guffon, E. L. Teles, M. C. S. Miranda, Z.-F. Yu, S. J. Swiedler, J. J. Hopwood, and for the MPS VI Study Group Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase Pediatrics, June 1, 2005; 115(6): e681 - e689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hinek, K. R. Braun, K. Liu, Y. Wang, and T. N. Wight Retrovirally Mediated Overexpression of Versican V3 Reverses Impaired Elastogenesis and Heightened Proliferation Exhibited by Fibroblasts from Costello Syndrome and Hurler Disease Patients Am. J. Pathol., January 1, 2004; 164(1): 119 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tomatsu, K. O. Orii, C. Vogler, J. Nakayama, B. Levy, J. H. Grubb, M. A. Gutierrez, S. Shim, S. Yamaguchi, T. Nishioka, et al. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease Hum. Mol. Genet., December 15, 2003; 12(24): 3349 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Barbosa, S. Garcia, V. Barbier-Chassefiere, J.-P. Caruelle, I. Martelly, and D. Papy-Garcia Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies Glycobiology, September 1, 2003; 13(9): 647 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tomatsu, K. O. Orii, C. Vogler, J. H. Grubb, E. M. Snella, M. Gutierrez, T. Dieter, C. C. Holden, K. Sukegawa, T. Orii, et al. Production of MPS VII mouse (Gustm(hE540A{middle dot}mE536A)Sly) doubly tolerant to human and mouse {beta}-glucuronidase Hum. Mol. Genet., May 1, 2003; 12(9): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Maccari, D. Gheduzzi, and N. Volpi Anomalous Structure of Urinary Glycosaminoglycans in Patients with Pseudoxanthoma Elasticum Clin. Chem., March 1, 2003; 49(3): 380 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tomatsu, K. O. Orii, C. Vogler, J. H. Grubb, E. M. Snella, M. A. Gutierrez, T. Dieter, K. Sukegawa, T. Orii, N. Kondo, et al. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis PNAS, November 12, 2002; 99(23): 14982 - 14987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hinek and S. E. Wilson Impaired Elastogenesis in Hurler Disease : Dermatan Sulfate Accumulation Linked to Deficiency in Elastin-Binding Protein and Elastic Fiber Assembly Am. J. Pathol., March 1, 2000; 156(3): 925 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akçay, D. Konukoglu, and Y. Dínçer Urinary glycosaminoglycan excretion in urolithiasis Arch. Dis. Child., March 1, 1999; 80(3): 271 - 272. [Abstract] [Full Text]
|
|
|
|
|
|
F Breier, S Fang-Kircher, K Wolff, and W Jurecka Juvenile hyaline fibromatosis: impaired collagen metabolism in human skin fibroblasts Arch. Dis. Child., November 1, 1997; 77(5): 436 - 440. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ohashi, K. Watabe, K. Uehara, W. S. Sly, C. Vogler, and Y. Eto Adenovirus-mediated gene transfer and expression of human beta -glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice PNAS, February 18, 1997; 94(4): 1287 - 1292. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
